FLT3-IN-10

CAS No. 2088735-51-5

FLT3-IN-10( 2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine )

Catalog No. M28938 CAS No. 2088735-51-5

FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 49 In Stock
2MG 30 In Stock
5MG 51 In Stock
10MG 88 In Stock
25MG 181 In Stock
50MG 262 In Stock
100MG 373 In Stock
200MG 507 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FLT3-IN-10
  • Note
    Research use only, not for human use.
  • Brief Description
    FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
  • Description
    FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine
  • Pathway
    Angiogenesis
  • Target
    FLT
  • Recptor
    neuropeptide Y (NPY) Y1 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2088735-51-5
  • Formula Weight
    254.26
  • Molecular Formula
    C15H11FN2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (491.62 mM)
  • SMILES
    FC=1C=CC(=CC1)C=2OC(=NC2)NC=3C=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Antal-Zimanyi I, et al. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist. Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32.
molnova catalog
related products
  • BGB-102

    BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.

  • FLT3-IN-1

    FLT3-IN-1 is a novel potent and selective Flt3 inhibitor with IC50 of 10 nM; against FLT3-ITD-expressing MV4-11 cells with IC50 of 6 nM.

  • HM43239 B

    HM43239 is an orally active and selective FLT3 inhibitor with IC 50 s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively.